These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 16847778
41. Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic. Way SW, Podojil JR, Clayton BL, Zaremba A, Collins TL, Kunjamma RB, Robinson AP, Brugarolas P, Miller RH, Miller SD, Popko B. Nat Commun; 2015 Mar 13; 6():6532. PubMed ID: 25766071 [Abstract] [Full Text] [Related]
42. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Akassoglou K, Bauer J, Kassiotis G, Pasparakis M, Lassmann H, Kollias G, Probert L. Am J Pathol; 1998 Sep 13; 153(3):801-13. PubMed ID: 9736029 [Abstract] [Full Text] [Related]
43. Mechanisms Governing Oligodendrocyte Viability in Multiple Sclerosis and Its Animal Models. Lei Z, Lin W. Cells; 2024 Jan 09; 13(2):. PubMed ID: 38247808 [Abstract] [Full Text] [Related]
44. Neuregulin in neuron/glial interactions in the central nervous system. GGF2 diminishes autoimmune demyelination, promotes oligodendrocyte progenitor expansion, and enhances remyelination. Marchionni MA, Cannella B, Hoban C, Gao YL, Garcia-Arenas R, Lawson D, Happel E, Noel F, Tofilon P, Gwynne D, Raine CS. Adv Exp Med Biol; 1999 Jan 09; 468():283-95. PubMed ID: 10635037 [Abstract] [Full Text] [Related]
45. Inhibition of myeloperoxidase by N-acetyl lysyltyrosylcysteine amide reduces experimental autoimmune encephalomyelitis-induced injury and promotes oligodendrocyte regeneration and neurogenesis in a murine model of progressive multiple sclerosis. Yu G, Zheng S, Zhang H. Neuroreport; 2018 Feb 07; 29(3):208-213. PubMed ID: 29266034 [Abstract] [Full Text] [Related]
46. The pathologic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: implications for multiple sclerosis. Carlson NG, Hill KE, Tsunoda I, Fujinami RS, Rose JW. J Neuroimmunol; 2006 May 07; 174(1-2):21-31. PubMed ID: 16516308 [Abstract] [Full Text] [Related]
48. Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia. Fang M, Yamasaki R, Li G, Masaki K, Yamaguchi H, Fujita A, Isobe N, Kira JI. Front Immunol; 2018 May 07; 9():2588. PubMed ID: 30464764 [Abstract] [Full Text] [Related]
50. Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis. Ribeiro R, Yu F, Wen J, Vana A, Zhang Y. Neuroscience; 2013 Dec 19; 254():427-42. PubMed ID: 24036373 [Abstract] [Full Text] [Related]
53. Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Vartanian T, Li Y, Zhao M, Stefansson K. Mol Med; 1995 Nov 19; 1(7):732-43. PubMed ID: 8612196 [Abstract] [Full Text] [Related]
58. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Garay L, Gonzalez Deniselle MC, Gierman L, Meyer M, Lima A, Roig P, De Nicola AF. Neuroimmunomodulation; 2008 Nov 19; 15(1):76-83. PubMed ID: 18667803 [Abstract] [Full Text] [Related]
60. C5b-9 complement complex in autoimmune demyelination: dual role in neuroinflammation and neuroprotection. Rus H, Cudrici C, Niculescu F. Adv Exp Med Biol; 2006 Nov 19; 586():139-51. PubMed ID: 16893070 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]